| Catalog_no |
ADMC1236 |
| Product_name |
IPI-549 |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
1660.00/3880.00/7000.00 |
| Specificity |
Target: PI3K. Fields: IPI-549 is an orally administered immuno-oncology development candidate that selectively inhibits PI3K-gamma. IC50: 16 nM (PI3Kγ), 3.2 μM (PI3Kα), 3.5 μM (PI3Kβ), >8.4 μM (PI3Kδ)[1] |
| Dilution |
IC50: 16 nM (PI3Kγ), 3.2 μM (PI3Kα), 3.5 μM (PI3Kβ), >8.4 μM (PI3Kδ)[1] |
| Purification |
>98% |
| Concentration |
靶点：PI3K;IC50： 16 nM (PI3Kγ), 3.2 μM (PI3Kα), 3.5 μM (PI3Kβ), >8.4 μM (PI3Kδ)[1] |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
IPI549,IPI 549 |
| Molecular Weight |
528.2 |
| Notes |
IPI-549 is an orally administered immuno-oncology development candidate that selectively inhibits PI3K-gamma. IC50: 16 nM (PI3Kγ), 3.2 μM (PI3Kα), 3.5 μM (PI3Kβ), >8.4 μM (PI3Kδ)[1] |
| Instructions |
 查看与下载 |
